Discover
BLRX
BioLineRx Ltd.
2.49
1 x 2.20
1 x 2.31
bid
ask
+
0.05
2.05%
1 @ 04:00 PM
2.54 +0.05 (2.13%)
| Ytd | -10.22% | |
| 1y | -35.74% |
2.44
day range
2.51
2.15
52 week range
4.56
| Open | 2.50 | Prev Close | 2.44 | Low | 2.44 | High | 2.51 | Mkt Cap | 10.86M |
| Vol | 2.55K | Avg Vol | 20.02K | EPS | N/A | P/E | N/A | Forward P/E | -1.06 |
| Beta | 0.87 | Short Ratio | 2.39 | Inst. Own | 3.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-23 | 50-d Avg | 2.75 | 200-d Avg | 2.86 | 1yr Est | 4.57 |
BLRX News
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 48.8% to $3.63 during Thursday's pre
benzinga.com
BioLineRx And Hemispherian To Present Preclinical Efficacy Of GLIX1 In Orthotopic Glioblastoma Model
BioLineRx Ltd. (NASDAQ:BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers EXoZymes (NASDAQ:EXOZ) stock increased by 7.5% to $7.18 during Wednesday's after-market
benzinga.com
BioLine Rx Q2 Sales $294.000K Miss $500.000K Estimate
BioLine Rx (NASDAQ:BLRX) reported quarterly sales of $294.000 thousand which missed the analyst cons
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 41.4% to $7.29 during Friday's pre-mark
benzinga.com
BioLineRx Announces $3.75M Registered Direct Offering Of ADSs At $2.78 Each And Concurrent Private P
BioLineRx Ltd. (NASDAQ:BLRX) (TASE: BLRX) ("BioLineRx" or the "Company"), a clinical